REPEAT:ASX ANNOUNCEMENTCELLESTIS LIMITED (CST)8 OCTOBER...

REPEAT:

ASX ANNOUNCEMENT
CELLESTIS LIMITED (CST)
8 OCTOBER 2004

Progress on FDA Approval
Previous statements by the Company have indicated that a response for Federal Drug Administration (FDA) approval of QuantiFERON-TB Gold may have been
expected by October, 2004.

Consequently the Company is updating the shareholders on the FDA situation.
At this time the Company has answered all questions posed to date by the FDA and we have no outstanding queries.

These queries from the FDA have included questions on clinical trials and suggested modifications to our Product literature, which provide test use instructions, indications for use, and clinical information.

All FDA questions and suggestions have been answered or incorporated in Company
literature.

We are advised to expect further communication from the FDA within the
next two weeks.
++++++++++++++++++++++++++++++

That was written a fortnight ago, so we must be close to receiving some news? The share price moved up strongly.